Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23432436 | 0.94 | GPR84 (0.37) | GPR84PIK3CAMTORPIK3CG | |
| SCHEMBL22181513 | 0.91 | GPR84 (0.35) | GPR84HDAC4HDAC2HDAC8 | |
| SCHEMBL22181359 | 0.88 | L3MBTL1 (0.30) | — | |
| SCHEMBL23432435 | 0.87 | GPR84 (0.36) | GPR84HDAC4HDAC2HDAC8 | |
| SCHEMBL22181301 | 0.86 | — | — | |
| SCHEMBL22159665 | 0.86 | GPR84 (0.30) | GPR84 | |
| SCHEMBL22181278 | 0.86 | — | — | |
| SCHEMBL22181515 | 0.86 | GPR84 (0.36) | GPR84HDAC4HDAC2HDAC8 | |
| SCHEMBL22181529 | 0.85 | ALDH1A1 (0.33) | GPR84TSHRHIF1A | |
| SCHEMBL22181669 | 0.85 | GPR84 (0.32) | GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11248009-B2 | Polycyclic aromatic compound, material for an organic device, organic electroluminescent element, display apparatus and lighting apparatus | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2022-02-15 | — | — | US | disclosed |
| US-20200207787-A1 | POLYCYCLIC AROMATIC COMPOUND, MATERIAL FOR AN ORGANIC DEVICE, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY APPARATUS AND LIGHTING APPARATUS | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11248009-B2 | Polycyclic aromatic compound, material for an organic device, organic electroluminescent element, display apparatus and lighting apparatus | TYR, AOC2, AOC1 | GPR84 3172/4885PIK3CA 3797/4885MTOR 909/4885 |
| US-20200207787-A1 | POLYCYCLIC AROMATIC COMPOUND, MATERIAL FOR AN ORGANIC DEVICE, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY APPARATUS AND LIGHTING APPARATUS | TYR, AOC2, AOC1 | GPR84 3172/4885PIK3CA 3797/4885MTOR 909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.